Rapid direct nucleic acid amplification test without RNA extraction for SARS-CoV-2 using a portable PCR thermocycler
Preprint
Abstract
There is an ongoing worldwide coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, confirmatory diagnosis is by reverse transcription polymerase chain reaction (RT-PCR), typically taking several hours and requiring a molecular laboratory to perform. There is an urgent need for rapid, simplified and cost-effective detection methods. We have developed and analytically validated a protocol for direct rapid extraction-free PCR (DIRECT-PCR) detection of SARS-CoV-2 without the need for nucleic acid purification. As few as 6 RNA copies per reaction of viral nucleocapsid (N) gene from respiratory samples such as sputum and nasal exudate can be detected directly using our one-step inhibitor-resistant assay. The performance of this assay was validated on a commercially available portable PCR thermocycler. Viral lysis, reverse transcription, amplification and detection are achieved in a single-tube homogeneous reaction within 36 minutes. This minimized hands-on time, reduces turnaround-time for sample-to-result and obviates the need for RNA purification reagents. It could enable wider use of Covid-19 testing for diagnosis, screening and research in countries and regions where laboratory capabilities are limiting.Keywords
All Related Versions
- Published version: Genes, 11 (6), 664.
This publication has 19 references indexed in Scilit:
- Spread of SARS-CoV-2 in the Icelandic PopulationNew England Journal of Medicine, 2020
- Temporal dynamics in viral shedding and transmissibility of COVID-19Nature Medicine, 2020
- Covid-19: testing timesBMJ, 2020
- COVID-19 in Singapore—Current ExperienceJAMA, 2020
- Fast, portable tests come online to curb coronavirus pandemicNature Biotechnology, 2020
- Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care DiagnosticsMicromachines, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- A Direct from Blood/Plasma Reverse Transcription–Polymerase Chain Reaction for Dengue Virus Detection in Point-of-Care SettingsThe American Journal of Tropical Medicine and Hygiene, 2019
- Development of a TaqMan® RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya virusesJournal of Virological Methods, 2005